TITLE

XCELLSYZ

PUB. DATE
August 2003
SOURCE
Worldwide Biotech;Aug2003, Vol. 15 Issue 8, p3
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Features Xcellsyz Ltd., a biotechnology company that focuses on the discovery of drugs for diabetes and obesity through the use of novel cell-based technologies.
ACCESSION #
10400312

 

Related Articles

  • XCELLSYZ IDENTIFIES MECHANISM OF ACTION OF XD4241 COMPOUND.  // Worldwide Biotech;Aug2003, Vol. 15 Issue 8, p2 

    Reports on the discovery of the mechanism of action of Xcellsyz Limited's antidiabetic compound XD4241.

  • pharmaceuticals & fine chemicals.  // Chemical Week;2/2/2005, Vol. 167 Issue 4, p21 

    Presents an update on pharmaceuticals and fine chemicals business as of February 2005. Terms of an agreement signed by Cambrex Bio Science Wokingham with biotechnology firm Xcellsyz; Collaboration agreement between Albany Molecular Research and Alcon Research to discover and develop ophthalmic...

  • in brief.  // Pharmaceutical Technology Europe;Dec2003, Vol. 15 Issue 12, p10 

    Presents news in brief on developments in the field of pharmaceutical technology. Development of SyntheChol, a synthetic cholesterol for use in cell culture and drug delivery applications by Sigma-Aldrich Fine Chemicals; Receipt of a huge grant for research and development by Xcellsyz, a...

  • Biotech--fact & fancy. Gopal, Kevin // Pharmaceutical Executive;Sep97, Vol. 17 Issue 9, p34 

    Focuses on the progress of the biotechnology industry in Europe. Formation of the company, EuroBio; Elements of the external business environment that influence biotechnology; Greater growth and market of biotechnology in the United States; Comparison on the biotechnology sector between the...

  • Are Biotech Stocks Back in Vogue? Burke, Jeanne // Bank Investment Consultant;Mar2003, Vol. 11 Issue 3, p32 

    Focuses on the stock market performance of biotechnology industries in the U.S. in the year 2002. Number of companies who gained profits among the 550 biotechnology companies; Reason behind the anticipated profitability for the industry in 2003.

  • Biotechnology firms.  // Business News New Jersey;1998 Book of Lists, Vol. 11, p20 

    Ranks biotechnology companies in New Jersey by number of employees. Includes Johnson & Johnson; Bristol-Myers Squibb; Novaris Pharmaceuticals; American Home Products; Hoffmann-La Roche; Warner-Lambert.

  • Top 50 biotechnology firms. Barbarello, Kathleen // Business News New Jersey;04/05/99, Vol. 12 Issue 14, p28 

    Ranks the top 50 biotechnology firms based on number of employees in New Jersey. Includes Johnson & Johnson; Bristol-Myers Squibb; Schering-Plough; American Home Products; Novartis Pharmaceuticals.

  • Go back to biotech drawing board. Kleiman, Herbert // Crain's Cleveland Business;3/24/2003, Vol. 24 Issue 12, p11 

    Calls for the need to promote biotechnology industry in Cleveland, Ohio. Lack of technology initiatives in the city; Relocation of biotechnology company Atherseys from Cleveland to Research Triangle Park, North Carolina.

  • Largest bioindustry companies in the Tucson area. Trower, Tanya // Inside Tucson Business;02/23/98, Vol. 7 Issue 48, p14 

    Lists the 20 largest bioindustry companies in Tucson, Arizona ranked by number of employees. Company name; Address and telephone number; Products; Public/private status; Business emphasis; Principals; Year established locally.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics